Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety (Q42163306)

From Wikidata
Jump to navigation Jump to search
scientific article published on April 2007
edit
Language Label Description Also known as
English
Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety
scientific article published on April 2007

    Statements

    Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety (English)
    David E Geller
    Michael W Konstan
    Jeffrey Smith
    Sarah B Noonberg
    Carol Conrad
    1 April 2007
    307-313

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit